嘉德诺Cardinal Health Inc. (CAH) 2012财年年度报告「NYSE」.pdf

1、Essential to care2012 Annual ReportFiscal 2012 was a year of considerable accomplishments.We achieved virtually all of our financial goals,including those for revenues,operating profit,earnings per share(EPS),margin rate growth and capital efficiency.We made excellent progress on our strategic prior

2、ities and continued to strengthen our organization by focusing on talent development and adding world-class leadership in key roles.Specifically,full-year fiscal 2012 revenues were up 5 percent to$107.6 billion,with non-GAAP operating earnings up 13 percent to$1.9 billion.1 Non-GAAP diluted earnings

3、 per share from continuing operations were$3.21,a 15 percent increase.In addition,our organization did another excellent job managing working capital,generating$1.2 billion in cash from operations for the full year.We returned$750 million of cash to shareholders in 2012,through both our differentiat

4、ed dividend payout and share repurchases.We took advantage of opportunities to make a few small acquisitions to expand our market penetration,product offerings and market coverage,deploying$174 million for acquisitions.Our balance sheet remains an important asset,as we ended the year with$2.3 billio

5、n in cash.It was also a year which brought its challenges,some foreseen,like commodity costs,and some others unexpected,particularly our issues with the Drug Enforcement Administration around controlled drug policy.But through this,we continue to grow,learn and adjust a necessary ingredient for any

6、thriving organization with bold long-term aspirations.Dear Shareholders of Cardinal Health:1See page 12 for a reconciliation of the differences between the non-GAAP financial measures and the most directly comparable GAAP financial measures.238107_Cardinal_CVR_R2.indd 21Pharmaceutical segment highli